Cancer Research UK Science and Innovation

We are thrilled to see Edith Heard appointed as the new Director and Chief Executive of the Francis Crick Institute. We look forward to witnessing the continued advancements in biomedical research under her guidance. Congratulations 👏

Thrilled to announce the June winner of our #ResearchIsBeautiful image campaign: Michaela Macdonald from Carcinotech Ltd Michaela’s image captures a 3D-bioprinted living tumour derived from donor glioblastoma tissue. Carcinotech specialises in crafting these bioengineered tumours from patient biopsies, offering researchers and drug developers an alternative to animal models for screening and testing cancer therapies. Interested in taking part? Drop us an email by 25th of each month with your wonderful moments of science to win our monthly pick. T&Cs apply. https://lnkd.in/efB-ujNF

What data do we already have that can help us understand less heard voices in research and publishing? How many publications contain fabricated, falsified or plagiarised data, and how should we deal with fake studies? The latest in our Research with Integrity series sees Andrew Porter (Research Integrity and Training Adviser at CRUK MI), Catherine Winchester (Head of the Research Integrity Service at our Scotland Institute) and the wider research integrity team give us the low-down of #ResearchIntegrity from the 8th World Conf Research Integrity #WCRI2024. Read along to find out what they think you should know about this culture change journey: https://lnkd.in/eYZGf3dn

The deadline is fast approaching🏃♂️⏰    If you're working on an exciting project in #PrecisionMedicine or molecular analysis, now is the time to share your innovative work with the research community.     Submit your abstract by 23 July for the chance to showcase your research to leading experts in the field.    Hear from our scientific co-chairs, Lisa Derosa (Gustave Roussy), Mariam Jamal-Hanjani (UCL) and Joaquin Mateo (Vall d'Hebron Institute of Oncology (VHIO)), on why you should submit an abstract for #MAP2024 👉 https://bit.ly/3R7JrT5    Learn more and submit your abstract here: https://bit.ly/3UIXwaF ESMO - European Society for Medical Oncology Unicancer

Our first ever annual Cancer Prevention Research Conference in partnership with the American Cancer Society and the National Cancer Institute (NCI) just took place in Boston. During these last three days, we had the opportunity to engage with over 350 attendees from all over the world to discuss the latest concepts in cancer prevention research. As we reflect on the insights gained from this first event, we’re happy to announce that Cancer Research UK will be hosting the 2025 conference in London, between 18 – 20 June.  Mark the date in your calendars and register your interest to be the first one to hear about when the registration opens. 🗓 Register your interest now: https://bit.ly/4cwakIU  Anbalakan Paramasivam | Timothy Rebbeck | David Crosby | William Dahut | John Burn | Jessica Faupel-Badger | Catherine Elliott | Thea Tlsty | Harvard University | Newcastle University | Cancer Research UK (CRUK) | #PrevConf24

Congratulations to Black in Cancer and Frederick National Laboratory for Cancer Research who put on the excellent 2024 Black in Cancer conference over two days last week, inspiring 200+ oncologists, cancer researchers, students, patient advocates and funders to get out of their comfort zones to enact change.   A prominent theme across the conference was the need to improve the diversity of clinical trials through patient and public involvement and further investigate the biological and social factors contributing to the higher mortality rate in Black cancer patients. We must continue to foster and engage with communities to improve both the quality of our research and health outcomes in the Black community.   A highlight of the event was the keynote address from Melissa Boneta Davis, lead of Cancer Grand Challenges team SAMBAI who are doing some pioneering work utilising quantified ancestry to unravel genetic vs. environmental influences in tumour biology among race/ethnic groups, including epigenetic cell signalling and immunological responses in the tumour microenvironment and systemic immune regulation.   It was fantastic to also see the great #CRUKFunded research presented by PhD students Adesewa Adebisi (Cancer Research UK Manchester Institute) Joanne Oke (Manchester Cancer Research Centre) and Sarah Williams (Cancer Research UK Beatson Institute) and our travel bursary recipients.   See more updates from the conference using #BiCconf24

In a recent #CRUKFunded publication in BMJ, Peter Sasieni and colleagues have shown that offering the HPV vaccine to girls aged between 12-13 prevents 90% of #CervicalCancer cases: https://lnkd.in/dcjxfWtZ Queen Mary University of London #CRUKscience

25 years ago, scientists showed that nearly all cervical cancers are caused by human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. Join us for a walk through our history in cervical cancer research over the past 70 years, from studies on cervical screening to the HPV vaccination programme and innovative trials on chemoradiotherapy: https://lnkd.in/eVrV-v8z

Are you interested in cancer screening and new approaches to early detection of cancer? Hear from the keynote speakers Peter Sasieni (Queen Mary University of London), Stephen Quake, D.Phil. (Stanford University), and Azra Raza (Columbia University) during our international conference. Join us between 22 -24 October in San Francisco for three days of thought-provoking discussions, and networking opportunities. Stay up to date with the agenda by following #EDxConf24. Canary Center | OHSU Knight Cancer Institute

The Cancer Research UK National Biomarker Centre is officially open, and we celebrated with a launch event on Friday 👏   The Centre is at the forefront of developing and testing biomarkers that could detect cancers earlier, predict relapse and optimise treatment for people affected by cancer.     We got a sneak peek of the state-of-the-art facilities and heard from Professor Caroline Dive. CBE (Director of the National Biomarker Centre), Nic Jones (Cancer Research UK Manchester Centre) and Susan Galbraith (AstraZeneca). We also viewed posters showcasing some of the groundbreaking biomarker research happening.     Find out more about the centre 👉 https://bit.ly/3V5VGke